You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Angiotensin-Converting Enzyme 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID 19 Trial in Secaucus (HLX71, Placebo)

Completed
  • COVID 19
  • Secaucus, New Jersey
    Frontage Clinical Services, Inc.
Mar 20, 2022

Covid19 Trial in Vienna (Angiotensin Converting Enzyme 2, Sodium chloride)

Completed
  • Covid19
  • Angiotensin Converting Enzyme 2
  • Sodium chloride
  • Vienna, Austria
    Medical University of Vienna
Sep 22, 2022

Oral Lesions, COVID-19, Angiotensin-converting Enzyme 2 Trial in Kafr Ash Shaykh (detection of oral lesions)

Completed
  • Oral Lesions
  • +2 more
  • detection of oral lesions
  • Kafr Ash Shaykh, Kafr El-sheikh, Egypt
    Dalia Rasheed Issa
Apr 1, 2022

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)

Not yet recruiting
  • Chronic Kidney Diseases
  • Placebo
  • Vitamin K 2
  • (no location specified)
Jul 4, 2023

Angiotensin-converting Enzyme 2 Expression in Tonsils and

Withdrawn
  • Adenoidectomy
  • Tonsillectomy
  • Storage of operating waste
  • Créteil, France
  • +8 more
Jul 5, 2021

Angiotensin Converting Enzyme, Brain, Gut Dysbiosis in Pulmonary

Active, not recruiting
  • Pulmonary Arterial Hypertension
    • Jacksonville, Florida
    • +1 more
    Jan 10, 2022

    COVID-19 Trial in Worldwide (RhACE2 APN01, Physiological saline solution)

    Completed
    Has Results
    • COVID-19
    • RhACE2 APN01
    • Physiological saline solution
    • Innsbruck, Austria
    • +21 more
    Jul 29, 2021

    Tranexamic Acid for Angiotensin-converting Enzyme

    Completed
    • Angioedema
      • Dallas, Texas
        Methodist Dallas Medical Center
      Oct 17, 2023

      Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

      Not yet recruiting
      • Diabetic Nephropathy Type 2
      • Empagliflozin 25 MG
      • Enalapril Maleate 20 mg
      • (no location specified)
      May 9, 2022

      Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)

      Completed
      Has Results
      • Type 2 Diabetes Mellitus
      • Hypertension
      • Placebo
      • +3 more
      • Nashville, Tennessee
        Vanderbilt University
      Feb 8, 2022

      Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor Trial in Saint Louis (High ACE Activity Fresh Frozen Plasma, Normal

      Recruiting
      • Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor
      • High ACE Activity Fresh Frozen Plasma
      • Normal Saline
      • Saint Louis, Missouri
        Barnes-Jewish Hospital
      Oct 24, 2022

      Angiotensin Converting Enzyme rs Gene Polymorphism and

      Recruiting
      • Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases
      • DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD
      • Sohag, Egypt
        Sohag university Hospital
      Sep 20, 2023

      Diabetic Kidney Disease Trial in Australia (SER150, Placebo)

      Recruiting
      • Diabetic Kidney Disease
      • Liverpool, New South Wales, Australia
      • +6 more
      May 17, 2022

      Angiotensin Converting Enzyme in Systemic Lupus Erythematous

      Not yet recruiting
      • Systemic Lupus Erythematosus
      • Angiotensin Converting Enzyme test
      • Sohag, Egypt
        Sohag University Hospital
      Aug 24, 2022

      Angiotensin Converting Enzyme Inhibitors and Angiotensin

      Not yet recruiting
      • COVID-19 Pneumonia
      • Covid_19
      • (no location specified)
      Jun 5, 2022

      Precision Treatment With Angiotensin Converting Enzyme Inhibitor

      Recruiting
      • Hypertension
      • +2 more
        • Seoul, Korea, Republic of
          Yonsei University Health System, Severance Hospital
        Sep 7, 2022

        Hypertension, COVID-19 Trial in Kiev (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers, Direct renin

        Completed
        Has Results
        • Hypertension
        • COVID-19
        • Angiotensin converting enzyme inhibitor
        • +2 more
        • Kiev, Please Select, Ukraine
          Medical Practice Prof D.Ivanov
        Feb 16, 2022

        C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality Trial in Sweden (Aliskiren, Enalapril)

        Recruiting
        • C3 Glomerulopathy
        • +4 more
        • Gothenburg, Sweden
        • +3 more
        Jan 4, 2022

        COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II

        Recruiting
        • COVID-19
        • Cardiovascular Diseases
        • Angiotensin converting enzyme inhibitor
        • Angiotensin II Receptor Blockers
        • Maceio, Alagoas, Brazil
        • +30 more
        Jan 13, 2023

        Chronic Kidney Diseases Trial (Placebo, Co-Enzyme Q10)

        Not yet recruiting
        • Chronic Kidney Diseases
        • Placebo
        • Co-Enzyme Q10
        • (no location specified)
        Jul 4, 2023

        COVID-19 Trial in Guangzhou (Recombinant human angiotensin-converting enzyme 2 (rhACE2))

        Withdrawn
        • COVID-19
        • Recombinant human angiotensin-converting enzyme 2 (rhACE2)
        • Guangzhou, Guangdong, China
          GCP Office of The First Affiliated Hospital of Guangzhou Medical
        Mar 15, 2020

        Surgery, Angiotensin Hypertension, Perioperative Complication Trial in Netherlands (drug, diagnostic test, behavioral)

        Recruiting
        • Surgery
        • +2 more
        • Perioperative withdrawal of angiotensin converting enzyme inhibitors and angiotenin receptor blockers
        • +4 more
        • Amsterdam, Netherlands
        • +6 more
        Jan 6, 2022

        Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2

        Recruiting
        • Diabetes Mellitus
        • Cardiovascular Diseases
        • Renin-angiotensin-aldosterone system inhibitors
        • +2 more
        • Singapore, Singapore
          Singapore General Hospital (SGH)
        Apr 28, 2021

        Bradykinin-degradating Enzymes Activities in

        Recruiting
        • Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
        • Assay of Bradykinin-degradating enzymes.
        • Grenoble, France
          Chu Grenoble Alpes
        Jan 14, 2022